Mpox is not COVID-19, but that pandemic’s bitter lessons have not all been learnt. By Peter Fabricius An ominous sense of déjà vu is...
Vous n'êtes pas connecté
The global vaccine group Gavi has up to $500-million to spend on getting shots to countries affected by an escalating mpox outbreak in Africa, its chief executive Sania Nishtar told Reuters.
Mpox is not COVID-19, but that pandemic’s bitter lessons have not all been learnt. By Peter Fabricius An ominous sense of déjà vu is...
RICH countries have several hundred million doses of vaccines that could help fight an mpox outbreak in Africa, where donated shots fall far short of...
RICH countries have several hundred million doses of vaccines that could help fight an mpox outbreak in Africa, where donated shots fall far short of...
(Reuters) -Rich countries have several hundred million doses of vaccines that could help fight an mpox outbreak in Africa, where donated shots fall...
(Reuters) -Rich countries have several hundred million doses of vaccines that could help fight an mpox outbreak in Africa, where donated shots fall...
The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.
While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored...
Experts have estimated they might need about 10 million vaccines to stop the ongoing outbreaks on the continent while donor countries have promised to...
Mpox is now present in 13 African countries, including Burundi, Congo-Brazzaville and the Central African Republic, according to the Africa CDC.
South Africa is one of 14 countries that the Africa Centres for Disease Control and Prevention and World Health Organization will financially help to...